RD

Ranjitbhai Deepsangbhai Dabhi

Active Director Director DIN 10800567
DIN 10800567 First appointment Oct 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Ranjitbhai Deepsangbhai Dabhi

Data last updated:

Ranjitbhai Deepsangbhai Dabhi is a Director at Aagraj Pharma Private Limited (since 2024). The company operates in Paper.

DIN 10800567
Primary Designation Director
Industry Paper
First Appointment 07 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aagraj Pharma Private Limited U21000GJ2024PTC155581
Director07 Oct 20242024Active

Board colleagues of Ranjitbhai Deepsangbhai Dabhi

NameDINCompanyDesignation
Tulsiben Udesagbhai Parmar10800568Aagraj Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aagraj Pharma Private Limited
Premium access

Shareholding and investment profile for Ranjitbhai Deepsangbhai Dabhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjitbhai Deepsangbhai Dabhi

Ranjitbhai Deepsangbhai Dabhi currently holds 1 directorship: Aagraj Pharma Private Limited (Director, since 07 Oct 2024).

Ranjitbhai Deepsangbhai Dabhi was first appointed on 07 Oct 2024 as Director at Aagraj Pharma Private Limited.

The current boards of Ranjitbhai Deepsangbhai Dabhi's companies include Tulsiben Udesagbhai Parmar (Aagraj Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available